Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jul 5, 2016 (10 years ago)

Oxygen Nasal Wash

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed Without An Approved NDA/ANDA: product is an unapproved drug due to nasal decongestant claims as well as not complying with the nasal decongestant final monograph.

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

Oxygen Nasal Wash (purified water, xylitol, stabilized oxygen, sodium chloride) solution, .75 oz (22mL) bottle, Distributed by: Let's Talk Health, Chula Vista, CA 91914.

Drug: Xylitol

Recalling firm
Let's Talk Health, Inc.
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1452-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Xylitol recalls

See all

Other unapproved drug recalls from 2016

All unapproved drug recalls
Class I · High risk

Domperidone capsules 10 mg

Marketed without an approved NDA/ANDA for which safety and efficacy has not been established.

Terminated Unapproved drug Jeffreys Drug Store D-0494-2017
Class II · Moderate risk

Zinc Acetate

Does not meet monograph: product exhibits lead levels in excess of the USP monograph limits.

Terminated Unapproved drug Spectrum Laboratory Products, Inc. D-1456-2016
Class II · Moderate risk

Fuqingsong Relief Cream

Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.

Terminated Unapproved drug Murray International Trading Co., Inc. D-1358-2016
Class II · Moderate risk

Te Xiao BaiNeiTing Herbal Supplement

Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.

Terminated Unapproved drug Murray International Trading Co., Inc. D-1357-2016